Combined Use of Different Vaccine Models for Covid-19 And The Side-Effect Profile: A Single-Center Experience

Author:

AVCI Ali1ORCID,ÖZER Muhammet1ORCID,YURDAKUL Mehmet Serkan1ORCID,OZER Hakan2ORCID,BALOĞLU İsmail3ORCID

Affiliation:

1. Karaman Training and Research Hospita

2. Konya City Hospital

3. NECMETTİN ERBAKAN ÜNİVERSİTESİ, MERAM TIP FAKÜLTESİ, MERAM TIP PR.

Abstract

Background Currently, the most effective method to combat the COVID-19 pandemic is vaccination. This study investigated whether the combined use of vaccines obtained by different methods affected the side-effect profile. Methods This cross-sectional study evaluated 437 people (265 females, 172 males; mean age, 42.04±14.49 years) who applied to the emergency department due to side effects among 26,974 vaccinated people (13,460 females, 13,514 males). The complaints and outcomes of the patients who applied to the emergency department were recorded. Results While the rate of admission to the emergency department due to post-vaccination side effects was 1.6% among all vaccinated participants, this rate was 3% in the mixed vaccination group. It was observed that hospitalization was required in only two patients due to side effects. When vaccination methods were compared, the frequency of admission to the emergency department due to side effects was higher in the patients in the group in which the mRNA vaccine was mixed with the booster shot. However, it was not statistically significant (p=0.113). Conclusion Different vaccine methods did not change the side effect profile, so different vaccine combinations could be used together if necessary.

Publisher

Turkish Journal of Internal Medicine

Subject

General Medicine

Reference16 articles.

1. WHO announces COVID-19 outbreak a pandemic. Europe: World Health Organization, 2020 [cited 2020 Apr 18]. Available at: https://www.euro.who.int/en/health-topics/health-emergencies/coronavirus-covid-19/news/news/2020/3/who-announces-covid-19-outbreak-a-pandemic. Accessed Feb 11, 2021.

2. Shimabukuro T. CDC COVID-19 Response Team; Food and Drug Administration. Allergic reactions including anaphylaxis after receipt of the first dose of Pfizer-BioNTech COVID-19 vaccine - United States, December 14-23, 2020. MMWR Morb Mortal Wkly Rep. 2021 Jan 15;70(2):46-51. doi: 10.15585/mmwr.mm7002e1.

3. Cucinotta D, Vanelli M. WHO Declares COVID-19 a Pandemic. Acta Biomed. 2020 Mar 19;91(1):157-160. doi: 10.23750/abm.v91i1.9397.

4. Oliver SE, Gargano JW, Marin M, Wallace M, Curran KG, Chamberland M, McClung N, Campos-Outcalt D, Morgan RL, Mbaeyi S, Romero JR, Talbot HK, Lee GM, Bell BP, Dooling K. The Advisory Committee on Immunization Practices' Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine - United States, December 2020. MMWR Morb Mortal Wkly Rep. 2020 Dec 18;69(50):1922-4. doi: 10.15585/mmwr.mm6950e2.

5. Centers for Disease Control and Prevention. What to expect at your appointment to get vaccinated for COVID-19| CDC. Vaccines. 2021. Available at: https://www.cdc.gov/coronavirus/2019-ncov/vaccines/expect.html. Accessed Feb 11, 2021.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3